Introduction
Of all the experiences of human conditions, childbirth surely represents the most important events. Amidst the complexity & sophistication of modern obstetrics, it is important to remember the simple objective of every pregnancy-delivery of a healthy baby to a healthy mother.
Postpartum hemorrhage is one of the commonest conditions encountered in day-to-day practice & is a nightmare even to the present day obstetrician. Nearly 50,000 to 60,000 women annually (WHO 1990 , UNICEF 1996 are still dying in developing countries & a substantial proportion of these deaths are due to PPH. Incidence being 5-10%of total maternal death where 90% is due to atonic PPH.
Maternal mortality rate so far reported in Nepal is 513 per 100,000 live births where postpartum (PPH) remains one of the commonest causes of death at turn of this century. The reason behind this is women out here are unable to cope with a larger amount of blood loss as they are smaller in built & therefore have less blood volume, malnourished & tend to have a lower antenatal hemoglobin level.
Prophylactic use of oxytocic drugs reduces the risk of PPH by approximately 40%. Active management of 3 rd stage of labor -is usually implemented as a "package" including early administration of an oxytocic during or immediately after the delivery of the baby, early cord clamping and cutting and controlled cord traction to deliver the placenta. Hence, the rational behind this study is to find out whether the prophylactic use of intramyometrial 15 methyl PGF 2α can reduce the incidence of PPH and further it can be used prophylactically especially in those patients where even minimal blood loss will adversely affect the health of mother.
Methods
This prospective randomized controlled study was conducted in 300 women in BPKIHS, Department of Obstetrics and Gynecology during the year [2004] [2005] . Patients who were admitted in labor room were chosen for the study after informed consent and fulfilling the inclusion and exclusion criteria.
Inclusion Criteria
Maternal Age <30 yrs, up to Para 4, estimated birth weight up to<3. 5 
Exclusion Criteria
Previous cesarean section or any other laparotomy scar, multiple pregnancies, intrauterine fetal death, polyhydroamnios, chorioamnionitis,, III o perineal tear, systemic illness (cardiac disease, D.M, asthma), coagulopathy, grand multi, macrosomic baby, prolonged labor, Rh negative blood group, hypertensive disorder, obese patients (fundus of the uterus is not easily accessible) and hypersensitivity to prostaglandin and methergin.
Once the women were in 2nd stage of labor, she was randomly grouped (computerized generator randomization) to one of the three groups to receive prophylactic oxytocic. Group A received intramyometrial 15-methyl PGF 2α , Group B received IM 15-methyl PGF 2α and Group C received IM methergin 0.2 mg immediately after delivery of fetus. For intramyometrial administration, patient was catheterized, abdomen prepared with betadine and draped in second stage of labor. Five cc syringe with 21 G needle was used. 250 mcg PGF 2α was injected transabdominally. While injecting resistance of myometrium was felt, plunger was slightly withdrawn and checked to rule out possibility of intravascular injection of drug.
Immediately following birth of the baby, a sterilized kidney tray was placed in close approximation to the vulva to collect the blood. Episiotomy site was covered with sterile gauze pieces and was discarded. After noting the signs of separation of the placenta, it was delivered by Brandt Andrew's method. 
Results
There were 300 normal parturient -low risk cases of vaginal deliveries, recruited for the study. Majority i.e. 68% of women was between 21-30yrs of age. There were 62.3% (187) primigravidas & 37.7% multigravidas. Mean gestational age was 40 weeks (280.87 days±12.1) and range was from 259 days to 375 days.
Most of the women studied were admitted in spontaneous labor, others were induced either with misoprostol or cerviprime gel. Average hemoglobin (Hb) level before delivery was 11.31 gm% (range-6.8gm% to 15.1gm%). All 3 groups were well matched in terms of age, gravidiy, parity, gestational age & Hb level (Table 1) .
Average birth weight of newborn baby (kg) was 2.93± 0.382 (range: 1.8-3.5). The median duration of active 1 st stage of labor was 149 mins (range: 45-480), 2 nd stage of labor was 11 mins (range: 2-60) & ruptured membrane was 152min (range: 3-720). However, the differences among different oxytocic groups were not statistically significant. (Table II) . A stratified analysis was done for primary outcome i.e., mean blood loss and subgroups of age, gravidity, parity, gestational age, birth weight of newborn, duration of labor and ruptured membrane in parturient. Except by the weight of newborn all other factors did not appear to influence the amount of blood loss. Higher weight of the babies had found to be statistically significant influenced on the amount of blood loss in all three groups. 
Discussion
Prostaglandins are 20-carbon atom "fatty acids" with a 5-member (cyclopentane) ring and two-side chain and the term were named by Von Euler (1935).
Prostaglandins are named A to I depends upon the structure of the carbon ring. 15-methyl PGF 2α is a synthetic compound that structurally resembles the naturally occurring prostaglandins and is one of the 1 st analogues to be developed for human use.
significant less blood loss compared to conventional uterotonics. Thus present study was carried out especially to see the efficacy of PGF 2α by intramyometrial or IM route, in reducing blood loss.
Three hundred low risk normal vaginal parturient were assigned to this study. We did not take high-risk cases for PPH as it may cause bias in the study. In the present study the average amount of blood lost at/ after delivery of placenta in one hour of observation by using prophylactic intramyometrial PGF 2α , which was 119.8ml compared to intramuscular PGF 2α , which was 172.65ml, and intramuscular methergin, 225.8ml. This was comparable to the other studies (2, 3, 4, 5, 6, 7) , since there are not many studies on blood loss during vaginal deliveries using intramyometrial PGF 2α , we compared to the blood loss during cesarean section.
Even mean duration of 3 rd stage of labor (mins) is comparable with other studies. (2, 4, 5, 6, 7, 8) Thus it could be proposed that, PGF 2α causes the process of placental separation faster and shorter the duration & decrease blood loss.
In present study those parturient, who received prophylactic intramyometrial PGF 2 α had no PPH, not required additional dose and not required any other form of other oxytocics. This might be explained by a sustained contraction of the uterus and subsequent reduction of blood loss. This could also be attributed to the fact that only low risk cases were taken in this study. Side effects like headache, vomiting, nausea were seen more common with PGF 2α but incidence was too low to allow for a meaningful analysis. Cochrane Database Systemic Review 2004 showed other side effects like abdominal pain, shivering and pyrexia (> 38 o c) in some studies with PGF 2α . In this study, we did not follow up these women in long term basis. But since none of the women came back with postpartum endometritis and secondary PPH, we assume that prophylactic use of intramyometrial PGF 2α , does not increase risk of endometritis.
Conclusion
Routine "active management" of 3 rd stage of labor with PGF 2α is superior to methergin in terms of blood loss & PPH. Moreover intramyometrial administration of PGF 2α is better than IM. Routine clinical application of direct intramyometrial injection of 15 -methyl PGF 2α is recommended in view of its easy performance, excellent hemostasis, minimal side effects and good prognosis especially in domiciliary or rural settings and especially in those patients where even minimal blood loss will adversely affect the health of mother.
